Gut Robert
SEC Form 4 insider trading activity
Gut Robert has filed 3 SEC Form 4 filings (13 transaction rows) across 1 company, with disclosures dating back to 2025. 2 of those filings fall inside the rolling window. Most recent filing: Jun 12, 2026.
On the most recent filing, Gut Robert is listed as Director at uniQure N.V. Inside the rolling window, Gut Robert reported no open-market purchases and 3 open-market sales totaling $901K in QURE. The largest disclosed transaction in the window is a sale of 25,613 QURE shares on Jan 12, 2026, worth $630K.
Companies traded
Other insiders at QURE
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$901K
reported sales (SEC code S)
Companies
1
in the rolling window
Earlier trades
Open-market purchases and sales filed before the rolling 365-day window, kept from the original Form 4 filings.
Frequently asked questions
How many SEC Form 4 filings has Gut Robert made?
Gut Robert has filed 3 SEC Form 4 filings (13 transaction rows) across 1 company since 2025.
Which companies does Gut Robert trade?
Gut Robert has filed SEC Form 4 disclosures for 1 company, including QURE.
When was Gut Robert's most recent SEC Form 4 filing?
Gut Robert's most recent SEC Form 4 filing on Tracefour is dated Jun 12, 2026.
What is Gut Robert's total buy and sell value in the current window?
Inside the rolling retention window, Gut Robert bought $0 and sold $901K based on SEC Form 4 filings.
What was Gut Robert's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 25,613 QURE shares on 2026-01-12, worth $630K, per SEC Form 4 filings.